Your browser doesn't support javascript.
loading
Checkpoint Kinase 2 Inhibition Can Reverse Tamoxifen Resistance in ER-Positive Breast Cancer.
Tsoi, Ho; Tsang, Wai-Chung; Man, Ellen P S; Leung, Man-Hong; You, Chan-Ping; Chan, Sum-Yin; Chan, Wing-Lok; Khoo, Ui-Soon.
Affiliation
  • Tsoi H; Department of Pathology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.
  • Tsang WC; Department of Pathology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.
  • Man EPS; Department of Pathology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.
  • Leung MH; Department of Pathology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.
  • You CP; Department of Pathology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.
  • Chan SY; Department of Clinical Oncology, Queen Mary Hospital, Hong Kong SAR, China.
  • Chan WL; Department of Clinical Oncology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.
  • Khoo US; Department of Pathology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.
Int J Mol Sci ; 23(20)2022 Oct 14.
Article in En | MEDLINE | ID: mdl-36293165
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tamoxifen / Breast Neoplasms Type of study: Prognostic_studies Limits: Female / Humans Language: En Journal: Int J Mol Sci Year: 2022 Document type: Article Affiliation country: China Country of publication: Suiza
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tamoxifen / Breast Neoplasms Type of study: Prognostic_studies Limits: Female / Humans Language: En Journal: Int J Mol Sci Year: 2022 Document type: Article Affiliation country: China Country of publication: Suiza